WashingtonBiotech lobbies sued Friday to halt a Medicare drug-price pilot.
Expected to have little impact, the pilot still sets a precedent the industry wants stopped.
The pilot ties Medicare drug prices to what peer countries pay, and the complaint argues it exceeds Medicare’s statutory authority.
The US District Court for Northern California has not ruled, and Medicare’s administrator has not commented.
How each outlet framed it
- STAT
- frames GLOBE as a precedent fight, not a budget one: says the pilot's savings are small but the Medicare authority question is what industry wants stopped
Sources: STAT